We focused on ADAM10 because it was found to be significantly upregulated in LRC (Fig. 1G) and is known to play an important role in the progression of T-ALL and cancers of multiple entities, as well as in normal hematopoiesis [26–37]. Here, ADAM10 is linked to acute lymphoblastic leukemia.